Blood Res.  2017 Dec;52(4):334-337. 10.5045/br.2017.52.4.334.

Comparison of the acute erythropoietic capacities of erythropoietin and U-74389G in terms of hemoglobin levels

• Tsompos C
• Panoulis C
• Toutouzas
• Triantafyllou A
• Zografos G
• Papalois A

• KMID: 2405077
• DOI: http://doi.org/10.5045/br.2017.52.4.334

Abstract

No abstract available.

MeSH Terms

Erythropoietin*
Erythropoietin

Reference

1. Tsompos C, Panoulis C, Toutouzas K, Zografos G, Papalois A. The effect of the antioxidant drug “U-74389G” on haemoglobin levels following a hypoxemia/re-oxygenation protocol in rats. J Crit Care Med. 2015; 1:102–106.

2. Tsompos C, Panoulis C, Toutouzas K, Zografos G, Papalois A. The short-term effect of erythropoietin on hemoglobin during ischemia reperfusion injury in rats. Fiziologia. 2013; 23:26–32.

3. Himmelfarb J, Ikizler TA, Ellis C, et al. Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial. J Am Soc Nephrol. 2014; 25:623–633.

4. Jilani T, Iqbal MP. Does vitamin E have a role in treatment and prevention of anemia. Pak J Pharm Sci. 2011; 24:237–242.

5. Martinez Mdel C, Afonso SG, Meiss RP, Buzaleh AM, Batlle A. Hepatic damage and oxidative stress induced by Griseofulvin in mice. Cell Mol Biol (Noisy-le-grand). 2009; 55:127–139.

6. Prats M, Font R, García C, et al. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients. Clin Nephrol. 2014; 81:419–426.

7. Martinez Mdel C, Afonso SG, Buzaleh AM, Batlle A. Protective action of antioxidants on hepatic damage induced by griseofulvin. ScientificWorldJournal. 2014; 2014:982358.

8. Goldstein BD, Harber LC. Erythropoietic protoporphyria: lipid peroxidation and red cell membrane damage associated with photohemolysis. J Clin Invest. 1972; 51:892–902.

9. Arslantaş MK, Arslantaş R, Tozan EN. Effects of systemic erythropoietin on ischemic wound healing in rats. Ostomy Wound Manage. 2015; 61:28–33.

10. Khodosovskiĭ MN, Zinchuk VV. Erythropoietin influence on the blood oxygen transport and prooxidant-antioxidant state during hepatic ischemia-reperfusion. Ross Fiziol Zh Im I M Sechenova. 2014; 100:592–601.

11. Kalantzi M, Kalliakmani P, Papachristou E, et al. Parameters influencing blood erythropoietin levels of renal transplant recipients during the early post-transplantation period. Transplant Proc. 2014; 46:3179–3182.

12. Hernández-Navarrete LS, Hernández-Jiménez JD, Jiménez-López LA, Budar-Fernández LF, Méndez-López MT, Martínez-Mier G. Experience in kidney transplantation without blood transfusion: kidney transplantation transfusion-free in Jehovah's Witnesses. First communication in Mexico. Cir Cir. 2013; 81:450–453.

13. Zabaneh R, Roger SD, El-Shahawy M, et al. Peginesatide to manage anemia in chronic kidney disease patients on peritoneal dialysis. Perit Dial Int. 2015; 35:481–489.

14. Bartnicki P, Kowalczyk M, Rysz J. The influence of the pleiotropic action of erythropoietin and its derivatives on nephroprotection. Med Sci Monit. 2013; 19:599–605.

15. Tsompos C, Panoulis C, Toutouzas K, Triantafyllou A, Zografos GC, Papalois A. Comparison of the attenuating capacities of erythropoietin and U-74389G concerning blood platelet counts. J Sci Achiev. 2017; 2:18–21.